{"transactions":[{"id":1480868,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-06-13T16:48:51.000Z","date":"2024-06-11","kind":"sale","planned":false,"acquired":false,"shares":85093,"price":5.53,"value":470564.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":4650571,"source":{"system":"sec-edgar","filing":"0000950170-24-073100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024073100/ownership.xml","form_type":"4"}},{"id":1538495,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-04-19T16:27:20.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":9688,"price":5.93,"value":57449.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":4735664,"source":{"system":"sec-edgar","filing":"0000950170-24-046030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024046030/ownership.xml","form_type":"4"}},{"id":1572640,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-03-18T17:11:39.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":44540,"price":6.33,"value":281938.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":4745352,"source":{"system":"sec-edgar","filing":"0000950170-24-032920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024032920/ownership.xml","form_type":"4"}},{"id":1581594,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:52:16.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":89586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024."}],"balance_after":4789892,"source":{"system":"sec-edgar","filing":"0000950170-24-030466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024030466/ownership.xml","form_type":"4"}},{"id":1581593,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:52:16.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":124826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 124,826 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":4700306,"source":{"system":"sec-edgar","filing":"0000950170-24-030466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024030466/ownership.xml","form_type":"4"}},{"id":1603533,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-03-04T18:50:46.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":115136,"price":8.02,"value":923390.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.00 to $8.25 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4575480,"source":{"system":"sec-edgar","filing":"0000950170-24-025136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017024025136/ownership.xml","form_type":"4"}},{"id":1724029,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-12-04T16:05:14.000Z","date":"2023-12-01","kind":"sale","planned":false,"acquired":false,"shares":113334,"price":6.54,"value":741204.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.46 to $6.64 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4690616,"source":{"system":"sec-edgar","filing":"0000950170-23-067737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023067737/ownership.xml","form_type":"4"}},{"id":1746884,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-08T18:23:36.000Z","date":"2023-11-07","kind":"sale","planned":false,"acquired":false,"shares":32056,"price":6.12,"value":196182.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4803950,"source":{"system":"sec-edgar","filing":"0000950170-23-061332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023061332/ownership.xml","form_type":"4"}},{"id":1746883,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-08T18:23:36.000Z","date":"2023-11-06","kind":"sale","planned":false,"acquired":false,"shares":300,"price":6.12,"value":1836.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."}],"balance_after":4836006,"source":{"system":"sec-edgar","filing":"0000950170-23-061332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023061332/ownership.xml","form_type":"4"}},{"id":1748774,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-06T16:30:08.000Z","date":"2023-11-03","kind":"sale","planned":false,"acquired":false,"shares":80977,"price":6.13,"value":496389.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4836306,"source":{"system":"sec-edgar","filing":"0000950170-23-059447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023059447/ownership.xml","form_type":"4"}},{"id":1767874,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-10-03T16:30:16.000Z","date":"2023-10-02","kind":"sale","planned":false,"acquired":false,"shares":113333,"price":6.61,"value":749131.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4917283,"source":{"system":"sec-edgar","filing":"0000950170-23-051565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023051565/ownership.xml","form_type":"4"}},{"id":1833040,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-07-07T17:27:55.000Z","date":"2023-07-06","kind":"sale","planned":false,"acquired":false,"shares":135400,"price":8.67,"value":1173918.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.31 to $8.97 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5030616,"source":{"system":"sec-edgar","filing":"0000950170-23-032287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023032287/ownership.xml","form_type":"4"}},{"id":1834137,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-07-06T16:30:37.000Z","date":"2023-07-05","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":8.72,"value":1308000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.63 to $8.96 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5166016,"source":{"system":"sec-edgar","filing":"0000950170-23-032034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023032034/ownership.xml","form_type":"4"}},{"id":1834136,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-07-06T16:30:37.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":54600,"price":9,"value":491400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.91 to $9.13 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5316016,"source":{"system":"sec-edgar","filing":"0000950170-23-032034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023032034/ownership.xml","form_type":"4"}},{"id":1843551,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-06-27T16:41:28.000Z","date":"2023-06-23","kind":"sale","planned":false,"acquired":false,"shares":65832,"price":9.02,"value":593804.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.97 to $9.10 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5370616,"source":{"system":"sec-edgar","filing":"0000950170-23-030155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000095017023030155/ownership.xml","form_type":"4"}},{"id":1923874,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-04-06T17:10:24.000Z","date":"2023-04-04","kind":"sale","planned":false,"acquired":false,"shares":69734,"price":7.61,"value":530675.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.46 to $7.77 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5436448,"source":{"system":"sec-edgar","filing":"0000899243-23-010874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323010874/doc4.xml","form_type":"4"}},{"id":1923873,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-04-06T17:00:15.000Z","date":"2023-04-04","kind":"sale","planned":false,"acquired":false,"shares":6399,"price":7.62,"value":48760.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":5506182,"source":{"system":"sec-edgar","filing":"0000899243-23-010864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323010864/doc4.xml","form_type":"4"}},{"id":1928894,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-04-04T20:00:25.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":97266,"price":7.43,"value":722686.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.17 to $7.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5512581,"source":{"system":"sec-edgar","filing":"0000899243-23-010555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323010555/doc4.xml","form_type":"4"}},{"id":1947465,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-17T16:30:11.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":43705,"price":6.14,"value":268348.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.23 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5609847,"source":{"system":"sec-edgar","filing":"0000899243-23-008876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323008876/doc4.xml","form_type":"4"}},{"id":1947464,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-17T16:30:11.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":200,"price":6.11,"value":1222.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5653552,"source":{"system":"sec-edgar","filing":"0000899243-23-008876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323008876/doc4.xml","form_type":"4"}},{"id":1952434,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-15T17:51:52.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":800,"price":6.11,"value":4888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5653752,"source":{"system":"sec-edgar","filing":"0000899243-23-008603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323008603/doc4.xml","form_type":"4"}},{"id":1959035,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-10T17:00:11.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":122295,"price":6.12,"value":748445.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.22 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5654552,"source":{"system":"sec-edgar","filing":"0000899243-23-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323008136/doc4.xml","form_type":"4"}},{"id":1963526,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-08T17:19:54.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":192307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 192,307 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":5776847,"source":{"system":"sec-edgar","filing":"0000899243-23-007559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924323007559/doc4.xml","form_type":"4"}},{"id":2147592,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-10-03T16:33:27.000Z","date":"2022-09-30","kind":"sale","acquired":false,"shares":82520,"price":7.03,"value":580115.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.20 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5584540,"source":{"system":"sec-edgar","filing":"0000899243-22-032431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924322032431/doc4.xml","form_type":"4"}},{"id":2232865,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-06-14T16:43:14.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":78858,"price":5.3,"value":417947.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":5667060,"source":{"system":"sec-edgar","filing":"0000899243-22-022399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924322022399/doc4.xml","form_type":"4"}},{"id":2290392,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-04-26T17:14:55.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":76446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 76,446 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":5745918,"source":{"system":"sec-edgar","filing":"0000899243-22-015669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924322015669/doc4.xml","form_type":"4"}},{"id":2291925,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":89936,"kind":"person","name":"Mullins Kevin Michael","position":1,"cik":"0001864233","reported_name":"Mullins Kevin Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-04-22T18:00:13.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":46283,"price":10.68,"value":494302.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.15 to $10.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5669472,"source":{"system":"sec-edgar","filing":"0000899243-22-015505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864233/000089924322015505/doc4.xml","form_type":"4"}}]}